Clinical Studies
Dementia due to cerebral vascular diseases cannot be differentiated by mental status examination from dementia due to the cerebral degenerative diseases (which may, in fact, inaccurately be labeled "degenerative"). The end-stage mental changes are the same, whatever the cause. The clinical processes, however, are different. A significant body of evidence about these processes comes from those clinicians who have closely and critically followed the course of patients with known cerebral vascular disease and those with identified cerebral disorders such as Alzheimer's disease. The course of cerebral vascular disease is characteristically marked by abrupt onset (which usually can be dated exactly), remissions and exacerbations, a stepwise or stuttering progression, focal neurological symptoms, and focal neurological signs. On the other hand, Alzheimer's disease and senile dementia Alzheimer type (SDAT), which are pathologically indistinguishable, are usually characterized by insidious onset which usually cannot be dated with exactness, a slow and inexorably progressive course without acute episodes, and the absence of focal neurological symptoms and signs.
With his characteristic close attention to clinical detail, Fisher 1 concluded some years ago that slowly progressive dementia (without acute episodes or focal neurological symptoms and signs) rarely results from cerebral vascular disease except in the patient with prolonged, sustained hypertension. At the same conference, Paulson and Perrine, 2 on the basis of their studies of chronically institutionalized demented patients, emphasized the infrequency with which dementia due to vascular disease lacked the specific clinical features pointing to vascular disease noted above. More recently Birkett, 3 in a careful clinicopathologic study of a small group also chronically hospitalized because of dementia, concluded that although psychological features could not differentiate multi-infarct dementia from that due to degenerative processes, a sudden onset plus focal neurological symptoms or signs strongly favored cerebral vascular disease.
These studies suggested that thorough clinical evaluation could distinguish multi-infarct dementia from dementia due to primary cerebral degenerative diseases, but the relative importance of vascular versus degenerative processes in the causation of dementia remained unclear. Three recently studied series of patients, admitted to major neurological teaching services specifically for investigation of their dementia, have provided the needed data. 4 
"
8 These patients were selected because dementia was the predominant manifestation of illness, not an epiphenomenon of already recognized systemic diseases. The diagnostic findings from these 3 series were summarized recently (see table I ). 7 The most pertinent data were that the dementia could be attributed to cerebral vascular disease in only 17 (8%) of the 222 patients, whereas in 113 (51%) the dementia was ascribed to atrophy of unknown cause. This atrophy is almost certainly largely due to Alzheimer's disease (vide infra). In patients evaluated primarily for dementia, therefore, cerebral vascular disease affords an acceptable explanation in only a small percentage.
Pathological Studies
The physician should inquire at this point, however, if these atrophies "of unknown cause" might not in fact be due to unrecognized strokes. The best evidence to the contrary is provided by the meticulous clinicopathological studies of Tomlinson, Blessed, and Roth." These workers reported their observations on 50 elderly patients who were evaluated before death because of their dementia and who came consecutively to autopsy from the wards of a mental hospital and a medical geriatric unit. As the authors noted, the series was not statistically representative of the elderly population with dementia, in part because it did not include patients with specific treatable disorders, and in part because males outnumbered females in the group. Nevertheless, because of this very selection process, their observations (see table 2 ) provide valuable data specifically about that group usually diagnosed as having "atrophy of unknown cause." Tomlinson, Blessed, and Roth found senile dementia Alzheimer type to account for 50% of their cases of dementia, to contribute equally with infarction in 8%, and to play some part in the dementing process in an additional 10%. Cerebral changes due to arteriosclerosis, on the other hand, accounted for only 12%, probably accounted for an additional 6%, contributed equally with Alzheimer's disease in 8%, and played perhaps some role in 10%. Even in patients with strokes, SDAT often contributed more to the causation of dementia than did cerebral infarction. Thus in this group, which might be thought weighted toward vascular disease because of its preponderance of males, Alzheimer's disease played a far more important role than did vascular disease. The evidence is, therefore, strongly against the assumption that most "atrophies of unknown cause" are due to diseases of the cerebral vasculature. Rather, most of these patients' brains are dominated by pathological findings typical of Alzheimer's disease -senile plaques, neurofibrillary tangles, and granulovacuolar degeneration. Is it possible that these pathologic features which specifically characterize Alzheimer's disease result themselves from vascular disease? It is, of course, impossible 9 reported a lack of correlation between the distribution and density of senile plaques and the distribution of arteriosclerotic plaques in the cerebral vasculature. Because fully developed senile plaques have an amyloid core, it has been suggested that intracerebral depositions of amyloid might provide nuclei for plaque formation. Amyloid deposition in the brain is not a feature of systemic amyloidosis, however, and electron microscopy has demonstrated that nerve terminal abnormalities precede the appearance of amyloid in the development of the senile plaque. 10 Mandybur" has described a type of congophilic angiopathy not infrequently present to some extent in Alzheimer's disease, but Alzheimer's disease may be severe in the absence of these congophilic vascular changes. Most authorities agree that vascular disease should not be indicted in the etiology of Alzheimer's disease.
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Implications
Granted that the pathological changes of Alzheimer's disease play a more important role than those of cerebral vascular disease in the etiology of dementia, is the distinction between these disorders important at this time? For several reasons, I believe that it is important both to differentiate these disorders clinically and to acknowledge publicly the statistical importance of Alzheimer's disease in the causation of dementia.
First, it is no longer tenable for the physician to diagnose dementia as such but then to forego a diligent search for the causative disease. Thorough diagnostic evaluation of patients with dementia leads to the recognition of potentially correctable disorders in 15% and of disorders which though not correctable nevertheless require specific therapeutic intervention in 20 to 25%. 7 Correctable disorders include depression, drug toxicity, normal pressure hydrocephalus, benign intracranial masses, mania, thyroid disease, pernicious anemia, epilepsy, hepatic failure and other chronic metabolic disturbances. Non-correctable disorders include multi-infarct dementia due to hypertension, malignant brain tumors, alcoholism, normal pressure hydrocephalus, neurosyphilis, and Huntington's chorea. Meticulous diagnostic study is required, therefore, to uncover disorders that call for specific therapeutic intervention.
For the remainder, the wastebasket diagnosis of "arteriosclerotic cerebral vascular disease" no longer suffices. Dementia due to vascular disease can usually be recognized on clinical grounds. Hachinski and coworkers 13 proposed an ischemia score derived from clinical evaluation which they used to separate "multi-infarct dementia" from "primary degenerative dementia." Although their ischemia score requires study in a larger number of patients (and perhaps further refinement), it exemplifies the sort of attention to detail which now should be afforded all patients with dementia. Patients with "primary degenerative dementia" should be diagnosed provisionally as Alzheimer's disease, because the vast majority of such patients will be shown to have Alzheimer's disease on pathological examination.
From a research standpoint, it is also important that the significance of Alzheimer's disease be recognized. Katzman and Karasu STROKE IN DEMENTIA/ Wells death in the United States, yet there is virtually no acknowledgment of its importance or even mention of it in vital statistics. When a patient dies with SDAT, the immediate cause of death (pneumonia, sepsis, etc.) rather than the underlying disease is usually recorded -and when the underlying cause is recorded, it is likely to be recorded incorrectly. Thus there is no widespread recognition of the role of Alzheimer's disease among the dementing diseases afflicting our population, and consequently research in its cause and treatment has lagged.
There is little cause to hope that a fuller understanding of cerebral vascular disorders, as important as that is, will elucidate the nature of Alzheimer's disease. The specific microscopic pathologic changes -senile plaques, neurofibrillary tangles, granulovacuolar degeneration -bear no predictable relationship to vascular changes. To the contrary, much accumulated evidence suggests that the study of genetic, toxic, biochemical, and possibly infectious factors offers more hope of unravelling the mysteries of the primary dementias than does the study of strokes and their causes. Recognition of the costs of these primary dementias both in terms of human suffering and in economic resources should lead to the allocation of a significant proportion of our research energies to their investigation.
Everything leads, therefore, to the conclusion that cerebral vascular disease is not the major cause of the commonly encountered dementias of middle and late life. Alzheimer's disease, whether senile or presenile, is the major culprit, and it must be recognized and studied sui generis. This does not, on the other hand, imply that cerebral vascular disease can be dismissed as unimportant in these patients' dysfunction. Although not often the sole explanation for these dementias, cerebral infarction may play a role in the clinical symptomatology in as much as 36% (see table  2 ). The clinical dysfunction due to Alzheimer's disease and to arteriosclerotic vascular disease is often additive. Thus Tomlinson 12 ' 15 and O'Brien 18 have both recently cautioned that although Alzheimer's disease is of greater numerical significance, the role of vascular disease is still important and should not be ignored. Were the problems of cerebral vascular disease solved, the overall incidence of dementia would clearly be reduced, and the morbidity of many patients with primary Alzheimer's disease (in whom infarction is often superimposed) would be lessened.
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